Good afternoon :)
Switch to
Add to Watchlist

Earum Pharmaceuticals Ltd

EARUM
Health CarePharmaceuticals
SmallcapWith a market cap of ₹64 cr, stock is ranked 2,144
Moderate RiskStock is 2.87x as volatile as Nifty
110.050.00 (+0.00%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹64 cr, stock is ranked 2,144
Moderate RiskStock is 2.87x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
-1,611.45
PB RatioPB Ratio
4.47
Dividend YieldDiv. Yield
Sector PESector PE
39.88
Sector PBSector PB
5.76
Sector Div YldSctr Div Yld
0.62%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Earum Pharmaceuticals is engaged in the pharmaceutical business involving marketing, trading and distribution of wide range of pharmaceutical formulation products such as anti-biotic drugs, anti-malarial drugs, anti-allergic & anti cold drugs etc

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

201820192020202135.8550.7557.3849.850.911.651.81-0.04
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

See detailed holdings

Recent EventsAll events 

Board Meeting 
Announced OnJul 31, 2021

Earum Pharmaceuticals Ltd - 542724 - Board Meeting Intimation for Intimation Of Board Meeting- Allotment ( Bonus Issue) | Download

Earum Pharmaceuticals Ltd - 542724 - Board Meeting Intimation for Intimation Of Board Meeting- Allotment ( Bonus Issue) | Download

Corp. Action 
Announced OnJul 29, 2021

Earum Pharmaceuticals Ltd - 542724 - Intimation For Record Date For Issue Of Bonus Equity Shares | Download

Earum Pharmaceuticals Ltd - 542724 - Intimation For Record Date For Issue Of Bonus Equity Shares | Download

Board Meeting 
Announced OnJul 27, 2021

Earum Pharmaceuticals Ltd - 542724 - Board Meeting Intimation for To Consider And Approve The Revised Audited Standalone Financial Results Of The Company For The Half Year And Year Ended On March 31, 2021 | Download

Earum Pharmaceuticals Ltd - 542724 - Board Meeting Intimation for To Consider And Approve The Revised Audited Standalone Financial Results Of The Company For The Half Year And Year Ended On March 31, 2021 | Download

See all events